"Dr. Noel's expertise in hematology and military medicine will be extremely valuable as we bring our transfusion products and advanced diagnostic capabilities to clinical application.”
Research Triangle Park, NC (PRWEB) March 05, 2015
North Carolina-based life sciences company Entegrion, Inc., announced that Pierre Noel, M.D., Professor of Medicine, Mayo Clinic College of Medicine, has been elected to the Company’s Board of Directors.
Entegrion’s Executive Chairman John B. Mowell said, “We are extremely fortunate to have Dr. Noel, a distinguished physician and researcher associated with the country’s leading healthcare organization, join Entegrion’s Board. His expertise in hematology and military medicine will be extremely valuable as we bring our transfusion products and advanced diagnostic capabilities to clinical application.”
Dr. Noel is Professor of Medicine at the Mayo Clinic College of Medicine, and is a Consultant, Division of Hematology/Oncology, Department of Internal Medicine at the Mayo Clinic in Scottsdale, Arizona. He also serves as Director of the Blood and Marrow Transplant Program in the Division of Hematology/Oncology at the Mayo Clinic. Dr. Noel previously served for several years as the Chief of Hematology and a Senior Clinician for the NIH Clinical Center in Bethesda, Maryland, and as a consultant to the White House Homeland Security Council in Washington, DC. He served as an officer in the military special operations community from 1997 through 2010, and is currently an advisor to the federal government on issues pertaining to medical support to counterterrorism operations.
Dr. Noel received his degree in medicine and completed an internal medicine residency at the University of Sherbrooke in Montreal, Canada. He completed a fellowship in hematology and was a foundation scholar at the Mayo Clinic College of Medicine in Rochester, Minnesota.
“During the past several months, Entegrion has successfully attracted leading healthcare professionals to its Board, with the addition of well known emergency medicine physician W. Brian Gibler in August of last year, and most recently with the appointment of Dr. Noel. The combined experience of these physicians in emergency and critical care medicine, hematology, and the business of healthcare has significantly strengthened our Board’s ability to guide the Company through the successful development and commercialization of its products,” Mowell said.
Entegrion, Inc. is a clinical stage life sciences product development company that is focused on improving the safety and availability of the world’s blood supply. Based in North Carolina’s Research Triangle Park, Entegrion offers patented technologies designed to overcome limitations in storage, safety, and availability of blood-derived products while preserving their functionality. Many of Entegrion’s advances in biologics are based on close collaborations with leading medical research institutions. Visit http://www.entegrion.com for more information.